BRTX - BioRestorative Therapies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue | 0.4 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.6 | 0.4 | 0.0 | 0.0 | 0 | 0 |
| Cost of Revenue | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0 | 0 |
| Gross Profit | 0.3 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | (0.2) | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0 | 0 |
| Operating Expenses | ||||||||||||||||
| R&D Expenses | 10.1 | 5.3 | 4.0 | 3.5 | 0.7 | 0.9 | 1.7 | 1.5 | 2.2 | 2.9 | 2.1 | 1.4 | 1.6 | 0.4 | 0.0 | 0.0 |
| SG&A Expenses | 5.9 | 6.6 | 11.3 | 15.6 | 25.6 | 2.0 | 6.8 | 6.2 | 6.3 | 4.9 | 5.4 | 3.7 | 3.2 | 5.2 | 3.5 | 2.1 |
| Other Expenses | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 | 0 | (0.1) | (0.0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 16.0 | 11.9 | 15.4 | 19.0 | 26.4 | 2.8 | 8.6 | 7.8 | 8.5 | 7.8 | 7.5 | 5.1 | 4.8 | 5.6 | 3.6 | 2.1 |
| Operating Income | ||||||||||||||||
| Operating Income | (15.6) | (11.6) | (15.2) | (18.9) | (26.3) | (2.8) | (8.4) | (7.6) | (8.4) | (7.8) | (7.2) | (4.9) | (4.8) | (5.6) | (3.6) | (2.1) |
| Interest Expense | 0 | 0 | 0 | 0 | 1.8 | 1.6 | 5.1 | 3.2 | 1.1 | 0.8 | 0.6 | 0.3 | 0.4 | 0.6 | 0.3 | 0.0 |
| Interest Income | 0.3 | 0.6 | 0.6 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||||
| EBITDA | (14.0) | (8.8) | (15.0) | (13.1) | (42.4) | (9.5) | (9.3) | (9.1) | (8.1) | (7.6) | (7.1) | (4.8) | (4.6) | (5.9) | (3.4) | (1.9) |
| EBIT | (14.2) | (9.0) | (15.1) | (13.2) | (42.5) | (9.6) | (9.5) | (9.3) | (8.4) | (7.9) | (7.3) | (4.9) | (5.0) | (5.6) | (3.5) | (2.1) |
| Income Before Tax | (14.2) | (9.0) | (10.4) | (13.2) | (44.3) | (11.3) | (14.6) | (12.5) | (9.4) | (8.6) | (7.9) | (5.6) | (5.8) | (6.5) | (4.1) | (2.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Net Income | (14.2) | (9.0) | (10.4) | (13.2) | (44.3) | (11.3) | (14.6) | (12.5) | (9.4) | (8.6) | (7.9) | (5.6) | (5.8) | (6.5) | (4.1) | (2.3) |
| Per Share Data | ||||||||||||||||
| EPS (Basic) | -31.60 | -23.20 | -49.40 | -73.00 | -746.00 | -571.20 | -52601.60 | -131246.40 | -139200.00 | -168000.00 | -256000.00 | -352000.00 | -560000.00 | -800000.00 | -26979.72 | -2115.70 |
| EPS (Diluted) | -31.60 | -23.20 | -49.40 | -73.00 | -746.00 | -571.20 | -52601.60 | -131246.40 | -139200.00 | -168000.00 | -256000.00 | -352000.00 | -560000.00 | -800000.00 | -26979.72 | -2115.70 |
| Shares Outstanding | 0.4 | 0.4 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||
| Cash & Cash Equivalents | 1.5 | 0.5 | 0.9 | 1.7 | 21.0 | 3.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 |
| Short-Term Investments | 1.4 | 10.2 | 10.2 | 13.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0 | 0 | (0.0) | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Other Current Assets | 0.2 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 |
| Total Current Assets | 3.1 | 11.1 | 11.4 | 15.1 | 21.5 | 3.2 | 0.1 | 0.2 | 0.5 | 0.1 | 0.3 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 |
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.7 | 0.2 | 0.3 | 0.5 | 0.6 | 0.5 | 0.0 | 0.1 | 0.1 | 0.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0.5 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.2 | 0.0 | 0.0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Other Non-Current Assets | 0.0 | 0.1 | 0 | 0.0 | (0.0) | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | (1.2) | 0.0 | 0 |
| Total Non-Current Assets | 0.9 | 1.1 | 1.2 | 1.3 | 1.0 | 1.2 | 1.4 | 1.0 | 1.2 | 1.5 | 1.7 | 1.6 | 1.1 | 1.2 | 0.1 | 0.5 |
| Total Assets | 4.1 | 12.3 | 12.6 | 16.4 | 22.5 | 4.3 | 1.5 | 1.2 | 1.8 | 1.6 | 2.0 | 1.7 | 1.4 | 1.3 | 0.2 | 0.5 |
| Current Liabilities | ||||||||||||||||
| Account Payables | 1.3 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | 2.0 | 1.9 | 2.5 | 2.3 | 2.5 | 1.1 | 1.3 | 0.8 | 0.4 | 0.2 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0.1 | 0 | 7.2 | 3.6 | 3.5 | 1.9 | 1.0 | 5.7 | 5.0 | 1.0 | 3.0 | 0.5 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 3.6 | 2.6 | 2.2 | 0 | 0.0 | 0.2 | 0 | 0 | 0.0 | 0 |
| Other Current Liabilities | 2.1 | 3.2 | 1.5 | 5.5 | 0.1 | 0.7 | (2.2) | 1.1 | 0.2 | 0.8 | 1.0 | 0.9 | 0.0 | 0.3 | 0.2 | 0.2 |
| Total Current Liabilities | 3.7 | 3.7 | 2.6 | 6.0 | 0.4 | 1.0 | 13.7 | 9.3 | 8.4 | 5.8 | 5.6 | 8.5 | 7.5 | 2.8 | 3.9 | 1.0 |
| Non-Current Liabilities | ||||||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0.2 | 4.3 | 0 | 0.5 | 0.2 | 0.3 | 0.3 | 0.1 | 0.5 | 3.6 | 0 | 0.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0.2 | 0.5 | 4.6 | 0.5 | 0.6 | 0.2 | 0.7 | 0.3 | 0.1 | 0.6 | 3.6 | 0 | 0.2 |
| Total Liabilities | 3.7 | 3.7 | 2.6 | 6.1 | 0.9 | 5.7 | 14.2 | 9.8 | 8.6 | 6.6 | 5.9 | 8.6 | 8.1 | 6.4 | 3.9 | 1.2 |
| Stockholders' Equity | ||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.6 | 0.5 |
| Retained Earnings | (169.9) | (155.7) | (146.7) | (136.3) | (134.1) | (89.8) | (78.6) | (63.9) | (51.4) | (42.0) | (33.3) | (25.4) | (19.8) | (14.1) | (7.5) | (3.5) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 0.4 | 8.5 | 10.0 | 10.3 | 21.6 | (1.3) | (12.8) | (8.6) | (6.8) | (5.0) | (3.9) | (6.9) | (6.7) | (5.1) | (3.7) | (0.7) |
| Total Liabilities & Equity | 4.1 | 12.3 | 12.6 | 16.4 | 22.5 | 4.3 | 1.5 | 1.2 | 1.8 | 1.6 | 2.0 | 1.7 | 1.4 | 1.3 | 0.2 | 0.5 |
| Debt Metrics | ||||||||||||||||
| Total Debt | 0 | 0 | 0.2 | 0.3 | 0.7 | 4.8 | 7.8 | 4.1 | 3.7 | 2.2 | 1.3 | 5.7 | 5.5 | 4.6 | 3.0 | 0.7 |
| Net Debt | (1.5) | (0.5) | (0.7) | (1.4) | (20.4) | 1.7 | 7.8 | 4.0 | 3.2 | 2.1 | 1.1 | 5.6 | 5.3 | 4.6 | 3.0 | 0.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Net Income | (14.2) | (9.0) | (10.4) | (13.2) | (44.3) | (11.3) | (14.6) | (12.5) | (9.4) | (8.6) | (7.9) | (5.6) | (5.8) | (6.5) | (4.1) | (2.3) |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Stock-Based Compensation | 3.3 | 2.8 | 7.8 | 12.6 | 23.1 | 0.7 | 1.7 | 2.4 | 3.6 | 2.5 | 2.0 | 1.4 | 0.8 | 1.8 | 0.5 | 0.9 |
| Change in Working Capital | 1.3 | 0.0 | 0.5 | 0.0 | 0.3 | 0.6 | 0.5 | (0.0) | 0.8 | 0.2 | 2.1 | 0.5 | 1.5 | 1.0 | 0.4 | 0.4 |
| Other Non-Cash Items | (1.4) | (2.3) | (4.5) | (5.4) | 17.5 | 7.9 | 4.2 | 3.2 | 0.9 | 0.6 | 0.1 | 0.1 | 0.2 | 2.2 | 0.3 | 1.1 |
| Operating Cash Flow | (10.8) | (8.2) | (6.4) | (5.9) | (3.3) | (2.0) | (6.9) | (5.1) | (3.9) | (5.0) | (3.1) | (3.2) | (2.7) | (3.2) | (2.8) | (0.7) |
| Investing Activities | ||||||||||||||||
| Capital Expenditure | (0.1) | (0.1) | (0.2) | (0.4) | (0.0) | 0 | (0.0) | (0.0) | (0.0) | (0.2) | (0.5) | (0.2) | (0.0) | (1.0) | (0.0) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (2.7) | (20.9) | (17.5) | (22.5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 11.7 | 21.5 | 21.0 | 9.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0.0 | 0 | (1) | 0.0 | 0 |
| Investing Cash Flow | 8.9 | 0.5 | 3.3 | (13.4) | (0.0) | 0 | (0.0) | (0.0) | (0.0) | (0.2) | (0.5) | (0.2) | (0.0) | (1.0) | 0.0 | (0.0) |
| Financing Activities | ||||||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0.2 | 5.5 | 5.2 | 4.2 | 2.2 | 1.4 | 1.2 | 0.6 | 1.4 | 2.2 | 2.7 | 0.2 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.3) | 7.4 | 0 | 0 | 0 | (0.5) | 0 | 0.4 | 1.0 | 0.1 | 0.4 | 0.1 | 0.5 | 0 | 0 | 0.0 |
| Financing Cash Flow | 2.9 | 7.4 | 2.3 | 0 | 21.3 | 5.0 | 6.8 | 4.8 | 4.3 | 5.1 | 3.7 | 3.3 | 2.9 | 4.1 | 2.9 | 0.8 |
| Cash Position | ||||||||||||||||
| Net Change in Cash | 1.0 | (0.3) | (0.8) | (19.3) | 18.0 | 3.1 | (0.1) | (0.3) | 0.4 | (0.1) | 0.1 | (0.1) | 0.2 | (0.1) | 0.1 | 0.0 |
| Cash at Beginning | 0.5 | 0.9 | 1.7 | 21.0 | 3.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 |
| Cash at End | 1.5 | 0.5 | 0.9 | 1.7 | 21.0 | 3.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 |
| Free Cash Flow | (10.9) | (8.3) | (6.6) | (6.4) | (3.4) | (2.0) | (7.0) | (5.1) | (3.9) | (5.2) | (3.6) | (3.4) | (2.7) | (4.2) | (2.8) | (0.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | 0.4 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.6 | 0.4 | 0.0 | 0.0 | 0 | 0 |
| Gross Profit | 0.3 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | (0.2) | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0 | 0 |
| Operating Income | (15.6) | (11.6) | (15.2) | (18.9) | (26.3) | (2.8) | (8.4) | (7.6) | (8.4) | (7.8) | (7.2) | (4.9) | (4.8) | (5.6) | (3.6) | (2.1) |
| Net Income | (14.2) | (9.0) | (10.4) | (13.2) | (44.3) | (11.3) | (14.6) | (12.5) | (9.4) | (8.6) | (7.9) | (5.6) | (5.8) | (6.5) | (4.1) | (2.3) |
| EPS (Diluted) | -31.60 | -23.20 | -49.40 | -73.00 | -746.00 | -571.20 | -52601.60 | -131246.40 | -139200.00 | -168000.00 | -256000.00 | -352000.00 | -560000.00 | -800000.00 | -26979.72 | -2115.70 |
| Balance Sheet | ||||||||||||||||
| Cash & Equivalents | 1.5 | 0.5 | 0.9 | 1.7 | 21.0 | 3.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 |
| Total Assets | 4.1 | 12.3 | 12.6 | 16.4 | 22.5 | 4.3 | 1.5 | 1.2 | 1.8 | 1.6 | 2.0 | 1.7 | 1.4 | 1.3 | 0.2 | 0.5 |
| Total Debt | 0 | 0 | 0.2 | 0.3 | 0.7 | 4.8 | 7.8 | 4.1 | 3.7 | 2.2 | 1.3 | 5.7 | 5.5 | 4.6 | 3.0 | 0.7 |
| Stockholders' Equity | 0.4 | 8.5 | 10.0 | 10.3 | 21.6 | (1.3) | (12.8) | (8.6) | (6.8) | (5.0) | (3.9) | (6.9) | (6.7) | (5.1) | (3.7) | (0.7) |
| Cash Flow | ||||||||||||||||
| Operating Cash Flow | (10.8) | (8.2) | (6.4) | (5.9) | (3.3) | (2.0) | (6.9) | (5.1) | (3.9) | (5.0) | (3.1) | (3.2) | (2.7) | (3.2) | (2.8) | (0.7) |
| Capital Expenditure | (0.1) | (0.1) | (0.2) | (0.4) | (0.0) | 0 | (0.0) | (0.0) | (0.0) | (0.2) | (0.5) | (0.2) | (0.0) | (1.0) | (0.0) | (0.0) |
| Free Cash Flow | (10.9) | (8.3) | (6.6) | (6.4) | (3.4) | (2.0) | (7.0) | (5.1) | (3.9) | (5.2) | (3.6) | (3.4) | (2.7) | (4.2) | (2.8) | (0.8) |